Since hyperglycosylated LAMP1 is observed with the activated microglia during the neuro-inflammatory process in NPC, treatment of Npc1−/− mice with HPβCD might be expected to reduce or eliminate the presence of hyperglycosylated LAMP1. This evidence concerns the gene LAMP1 and nasopharyngeal carcinoma.